金吾财讯 | 华润医药(03320)公布，附属公司华润三九截至去年12月31日止年度初步财务资料，纯利约33.7亿元(人民币，下同)，同比上升18.1%，每股盈利2.63元，扣除非经常性收益或亏损后的纯利31.2亿元，同比上升14.9%。
期内，华润三九营业总收入276亿元，同比上升11.63%，营业利润约44.7亿元，同比上升19.28%。
另外，集团连同华润三九合共持有约28.05%权益的昆药集团去年度纯利约6.5亿元，比2023年追溯调整前纯利同比上升45.74%，每股盈利86分，营业总收入84亿元，同比上升9%，营业利润9.3亿元，同比上升63.13%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.